XML 21 R4.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues        
Product revenue, net $ 214 $ 341 $ 1,900 $ 1,004
Operating expenses        
Cost of goods sold 1,170 512 1,311 546
Research and development 5,101 19,619 24,534 74,392
Selling, general and administrative 7,683 24,344 30,398 73,810
Restructuring costs 1,553 4,163 2,409 4,163
Total operating expenses 15,507 48,638 58,652 152,911
Loss from operations (15,293) (48,297) (56,752) (151,907)
Other expense (income)        
Interest expense 3,790 3,252 11,097 9,879
Interest income (616) (1,068) (2,234) (4,703)
Other (income) expense, net (4,817) 5 (16,875) (286)
Net loss $ (13,650) $ (50,486) $ (48,740) $ (156,797)
Basic net loss per share attributable to common stockholders (in dollars per share) $ (0.32) $ (1.72) $ (1.29) $ (5.40)
Diluted net loss per share attributable to common stockholders (in dollars per share) $ (0.32) $ (1.72) $ (1.29) $ (5.40)
Weighted average shares outstanding - basic (in shares) 42,390 29,268 37,853 29,026
Weighted average shares outstanding - diluted (in shares) 42,390 29,268 37,853 29,026